Friday, March 31, 2023 7:09:01 PM
I certainly acknowledge that Revive has to own a bit of the process. But it is clear that the FDA gets to play king maker. They can control the tempo of the trial, move the target just enough so that the little guys struggle to change course, add a little more to what is required in testing, etc...
Throughout Revive's course we would receive the occasional update that the FDA was going to hand hold them to and through the next phase. But the timelines that we would be given was something crazy like 3-4 months at a time. When that time would lapse, the landscape would have changed just enough that we could see relevancy slipping.
We may never know all of what was truly behind it. Very likely some dropped balls on Revive's part. But in the meantime, the big's were basically being fast tracked left and right, only months or years later to learn that corners were cut in testing, or in some cases data was falsified (bad or damning data was intentionally left out), and they floated through unchecked.
Maybe there is hope yet. But I think most of us now understand that the FDA doesn't truly have the publics best interest at hand.
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM
Element79 Gold Corp Announces 2024 Clover Work Plans & Nevada Portfolio Updates • ELMGF • Sep 10, 2024 11:00 AM
Nightfood Holdings Inc. Completes Major Step on Uplist Journey by Closing Strategic All-Stock Acquisition of CarryoutSupplies.com • NGTF • Sep 10, 2024 8:15 AM
Element79 Gold Corp. Announces Sale of 100% Interest in Elder Creek, North Mill Creek, and Elephant Projects to 1472886 B.C. Ltd. • ELEM • Sep 9, 2024 9:34 AM